0000-0002-5599-6648 About
A pharmaceutical scientist specializing in translational nanomedicine, targeted drug delivery, and biopharmaceutics. My research focuses on the design, optimization, and biological validation of advanced drug delivery systems, particularly intranasal and nano-enabled platforms for brain targeting and neuro-oncological applications. I have extensive experience in integrating in vitro, ex vivo, and in vivo models to evaluate therapeutic efficacy and pharmacokinetic–pharmacodynamic relationships. My work bridges formulation science with molecular and preclinical pharmacology, contributing to peer-reviewed publications in international journals. My broader research interests include physiological-based drug delivery, translational therapeutics, and interdisciplinary biomedical research aimed at improving treatment outcomes in complex diseases.
Employment
-
Marathwada Mitra Mandal's College of Pharmacy Assistant Professor2026 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (25)
- Intranasal delivery of nanocarriers for haloperidol: QbD development and pharmacodynamic evaluation in sporadic Alzheimer's disease rat model Save
- Formulation development of fenticonazole nitrate-loaded lipoidal nanocarriers for mixed vaginitis: Optimization, in vitro-ex vivo assessment, and pharmacodynamic investigations Save
- Nose-to-brain delivery of empagliflozin-loaded nanostructured lipid carriers incorporated in-situ gel: Biopharmaceutical evaluation for Alzheimer’s disease Save
- Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential Save
- Microemulsion-based dual delivery of malkangani and phalsa: formulation, optimization and in-vivo pharmacodynamics in rats Save
- QbD-enabled formulation development of imatinib using self-nanoemulsifying drug delivery system in nose-to-brain treatment of Glioblastoma Save
- Intranasal atorvastatin-loaded vitamin E TPGS lipoidal nanocarriers for glioblastoma: QBD-enabled formulation development and pharmacological investigations Save
- Intranasal teriflunomide-loaded lipid-based nanocarriers an improved remyelination potential in multiple Sclerosis: In-vitro, pharmacological, and toxicological assessments Save
- Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques Save
- Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model Save